Historical Stock Chart
3 Months : From Nov 2019 to Feb 2020
By Giulia Petroni
The European Union on Wednesday approved Danaher Corp.'s (DHR) acquisition of GE Healthcare Life Sciences' biopharma business, subject to conditions.
The European Commission said Danaher committed to sell businesses that posed competition concerns. The acquisition is conditional on Danaher's compliance.
In February, General Electric Co. (GE) agreed to sell the business to Danaher for about $21 billion.
Both Danaher and the GE Healthcare Life Sciences' biopharma business are active in the manufacturing of products and services used in bioprocessing industries and compete in other life-sciences areas.
Write to Giulia Petroni at email@example.com
(END) Dow Jones Newswires
December 18, 2019 13:12 ET (18:12 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.